BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 303116)

  • 21. Calcium-sensitive thermal transitions and domain structure of human complement subcomponent C1r.
    Busby TF; Ingham KC
    Biochemistry; 1987 Aug; 26(17):5564-71. PubMed ID: 2823884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.
    Arlaud GJ; Reboul A; Sim RB; Colomb MG
    Biochim Biophys Acta; 1979 Jan; 576(1):151-62. PubMed ID: 760802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.
    Cooper NR; Ziccardi RJ
    J Immunol; 1977 Nov; 119(5):1664-7. PubMed ID: 915274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and function of the serine-protease subcomponents of C1: protein engineering studies.
    Gál P; Závodszky P
    Immunobiology; 1998 Aug; 199(2):317-26. PubMed ID: 9777415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration and quantitation of activation of the first component of complement in human serum.
    Ziccardi RJ; Cooper NR
    J Exp Med; 1978 Feb; 147(2):385-95. PubMed ID: 75238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the first component of human complement (C1) by antibody-antigen aggregates.
    Dodds AW; Sim RB; Porter RR; Kerr MA
    Biochem J; 1978 Nov; 175(2):383-90. PubMed ID: 743203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
    Sim RB; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
    [No Abstract]   [Full Text] [Related]  

  • 29. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
    Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
    Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.
    Lacroix MB; Aude CA; Arlaud GJ; Colomb MG
    Biochem J; 1989 Feb; 257(3):885-91. PubMed ID: 2539098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel human complement-related protein, C1r-like protease (C1r-LP), specifically cleaves pro-C1s.
    Ligoudistianou C; Xu Y; Garnier G; Circolo A; Volanakis JE
    Biochem J; 2005 Apr; 387(Pt 1):165-73. PubMed ID: 15527420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.
    Reboul A; Bensa JC; Colomb MG
    Biochem J; 1986 Jan; 233(2):559-64. PubMed ID: 3006672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human complement serine proteases C1r and C1s and their proenzymes.
    Arlaud GJ; Thielens NM
    Methods Enzymol; 1993; 223():61-82. PubMed ID: 8271968
    [No Abstract]   [Full Text] [Related]  

  • 34. Isolation of human complement subcomponents C1r and C1s in their unactivated, proenzyme forms.
    Lane PD; Schumaker VN; Tseng Y; Poon PH
    J Immunol Methods; 1991 Aug; 141(2):219-26. PubMed ID: 1880428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Randazzo BP; Dunn JT; Silverberg M; Kaplan AP
    J Clin Invest; 1983 May; 71(5):1450-6. PubMed ID: 6304147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study on the structure and interactions of the C1 sub-components C1r and C1s in the fluid phase.
    Arlaud GJ; Chesne S; Villiers CL; Colomb MG
    Biochim Biophys Acta; 1980 Nov; 616(1):105-15. PubMed ID: 7437447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural biology of C1.
    Arlaud GJ; Gaboriaud C; Thielens NM; Rossi V
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1001-6. PubMed ID: 12440961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.